Invesaro

Stocks Consumer discretionary NSTM

OTC · Consumer discretionary

NovelStem International Corp. (NSTM)

It posted a net loss of $307.6K. At June 30, 2026 it held $56.2K in cash against $1.4M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

Watch NSTM in 60 seconds
Price
$0.01
0.00% on the day · September 28, 2026
52-week range $0.01 to $0.04
Market cap
$468.7K
P/E
0.2
on FY2025 diluted EPS

What NovelStem International Corp. does

NovelStem International Corp. is registered with the SEC under industry code SIC 5990 (Retail-Retail Stores, NEC). Its shares trade on OTC under the ticker NSTM.

Revenue and profit by year

Revenue
FY11: $4M $4M FY11FY11: $1.1M $1.1M FY11FY12: $616.3K $616.3K FY12
Net income
FY11: $4.9M $4.9M FY11FY11: -$6.9M -$6.9M FY11FY12: $10.4M $10.4M FY12FY22: -$1.3M -$1.3M FY22FY22: -$765.7K -$765.7K FY22FY23: -$4.2M -$4.2M FY23FY24: -$3.2M -$3.2M FY24FY25: $2.4M $2.4M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025n/a-$238.8K$2.4M$0.05n/a
2024n/a-$927.9K-$3.2M-$0.07n/a
2023n/a-$3.5M-$4.2M-$0.09n/a
2022n/a-$422.4K-$765.7K-$0.02n/a
2022n/a-$495.5K-$1.3M-$0.03n/a
2012$616.3K-$5.7M$10.4M$0.45-$4M

Full financial statements: income, balance sheet and cash flow

Next report expected around November 11, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 12, 2025. Not a date the company has announced. See the report calendar

Latest SEC filings

What NovelStem International Corp. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 14, 2026
    Quarterly report 10-Q · period to June 30, 2026Diluted EPS $0.00 versus $0.06.
  2. May 15, 2026
    Quarterly report 10-Q · period to March 31, 2026Diluted EPS $0.00 versus $0.00.
  3. March 26, 2026
    Annual report 10-K · period to December 31, 2025Diluted EPS $0.05 versus -$0.07.
  4. November 12, 2025
    Quarterly report 10-Q · period to September 30, 2025Net loss of $77.4K.
  5. August 6, 2025
    Quarterly report 10-Q · period to June 30, 2025Diluted EPS was $0.06.
  6. May 19, 2025
    Quarterly report 10-Q · period to March 31, 2025Diluted EPS was $0.00.
  7. May 15, 2025
  8. April 7, 2025
    Annual report 10-K · period to December 31, 2024Diluted EPS -$0.07 versus -$0.09.
  9. April 1, 2025
  10. November 14, 2024
    Quarterly report 10-Q · period to September 30, 2024Diluted EPS was -$0.05.

Recent insider filings (Forms 3, 4 and 144): 10, the latest on November 20, 2013. Insider transactions on SEC

All filings on SEC EDGAR

Questions about NSTM

What does NovelStem International Corp. do?

NovelStem International Corp. is registered with the SEC under industry code SIC 5990 (Retail-Retail Stores, NEC). Its shares trade on OTC under the ticker NSTM.

Is NovelStem International Corp. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $307.6K.

When did NovelStem International Corp. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026.

Similar companies

Compare NSTM with

Compare NSTM with any company

Follow NSTM

Get an email when NovelStem International Corp. files with the SEC: results, executive changes, material agreements and annual reports.

Follow NSTM: get an email when it files

Where the numbers come from

Financial figures are the values NovelStem International Corp. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.